Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141459 |
| CAS No | NA |
| Mol.F. | C14H20N6O3S |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141460 |
| CAS No | NA |
| Mol.F. | C14H20N6O3S |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141461 |
| CAS No | NA |
| Mol.F. | C13H18N6O3S |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141462 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141463 |
| CAS No | NA |
| Mol.F. | C21H26N6O5S |
| Mol.Wt. | 474.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141464 |
| CAS No | NA |
| Mol.F. | C21H26N6O5S |
| Mol.Wt. | 474.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141465 |
| CAS No | 14300-08-4 |
| Mol.F. | C10H12N2O2 |
| Mol.Wt. | 192.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141466 |
| CAS No | NA |
| Mol.F. | C10H11N3O4 |
| Mol.Wt. | 237.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141467 |
| CAS No | NA |
| Mol.F. | C21H26N6O5S |
| Mol.Wt. | 474.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141468 |
| CAS No | NA |
| Mol.F. | C21H24N8O7S |
| Mol.Wt. | 532.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141469 |
| CAS No | NA |
| Mol.F. | C21H25N7O6S |
| Mol.Wt. | 503.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141470 |
| CAS No | NA |
| Mol.F. | C21H25N7O6S |
| Mol.Wt. | 503.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141471 |
| CAS No | NA |
| Mol.F. | C21H21FN4O5 |
| Mol.Wt. | 428.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141472 |
| CAS No | NA |
| Mol.F. | C9H10N2O |
| Mol.Wt. | 162.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141473 |
| CAS No | NA |
| Mol.F. | C21H23FN4O4 |
| Mol.Wt. | 414.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141474 |
| CAS No | NA |
| Mol.F. | C13H19FN4O3 |
| Mol.Wt. | 298.3 |
| INV STATUS | CUSTOM SYNTHESIS |